Nathan J. Dowden - 15 Sep 2022 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Chief Operating Officer
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Issuer symbol
TRDA
Transactions as of
15 Sep 2022
Net transactions value
-$1,501
Form type
4
Filing time
19 Sep 2022, 16:34:16 UTC
Previous filing
12 Sep 2022
Next filing
23 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRDA Common Stock Sale $1,501 -100 -0.15% $15.01 68,648 15 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2022.